D. E. Shaw & Co., Inc. Travere Therapeutics, Inc. Transaction History

D. E. Shaw & Co., Inc.

$100 Billion
Q1 2025

A detailed history of D. E. Shaw & Co., Inc. transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 1,713,592 shares of TVTX stock, worth $26.3 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

1,713,592

Previous 2,278,375 24.79%

Holding current value

$26.3 Million

Previous $39.7 Million 22.63%

% of portfolio

0.03%

Previous 0.03%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$17.07 - $23.75 $9.64 Million - $13.4 Million	-564,783 Reduced 24.79%	1,713,592 $30.7 Million
Q4 2024 Feb 14, 2025	BUY	$13.65 - $19.85 $5.98 Million - $8.7 Million	438,306 Added 23.82%	2,278,375 $39.7 Million
Q3 2024 Nov 14, 2024	BUY	$7.89 - $15.21 $2.42 Million - $4.67 Million	306,997 Added 20.02%	1,840,069 $25.7 Million
Q2 2024 Aug 14, 2024	SELL	$5.26 - $8.28 $1.64 Million - $2.58 Million	-311,591 Reduced 16.89%	1,533,072 $12.6 Million
Q1 2024 May 15, 2024	BUY	$7.18 - $9.82 $1.34 Million - $1.83 Million	186,516 Added 11.25%	1,844,663 $14.2 Million
Q4 2023 Feb 14, 2024	BUY	$5.44 - $9.5 $3.67 Million - $6.41 Million	674,602 Added 68.59%	1,658,147 $14.9 Million
Q3 2023 Nov 14, 2023	SELL	$7.64 - $17.25 $2.12 Million - $4.79 Million	-277,459 Reduced 22.0%	983,545 $8.79 Million
Q2 2023 Aug 14, 2023	BUY	$15.3 - $22.61 $4 Million - $5.91 Million	261,513 Added 26.16%	1,261,004 $19.4 Million
Q1 2023 May 15, 2023	BUY	$17.82 - $22.89 $9.49 Million - $12.2 Million	532,651 Added 114.1%	999,491 $22.5 Million
Q4 2022 Feb 14, 2023	BUY	$18.47 - $26.14 $1.68 Million - $2.38 Million	90,997 Added 24.21%	466,840 $9.82 Million
Q3 2022 Nov 14, 2022	SELL	$22.91 - $28.63 $1.21 Million - $1.52 Million	-52,984 Reduced 12.36%	375,843 $9.26 Million
Q2 2022 Aug 15, 2022	SELL	$20.94 - $30.01 $975,259 - $1.4 Million	-46,574 Reduced 9.8%	428,827 $10.4 Million
Q1 2022 May 16, 2022	BUY	$23.61 - $30.6 $3.02 Million - $3.92 Million	128,060 Added 36.87%	475,401 $12.3 Million
Q4 2021 Feb 14, 2022	SELL	$24.34 - $31.17 $1.42 Million - $1.82 Million	-58,496 Reduced 14.41%	347,341 $10.8 Million
Q3 2021 Nov 15, 2021	SELL	$12.98 - $25.03 $10.3 Million - $19.8 Million	-791,961 Reduced 66.12%	405,837 $9.84 Million
Q2 2021 Aug 16, 2021	SELL	$14.11 - $26.4 $3.93 Million - $7.36 Million	-278,681 Reduced 18.87%	1,197,798 $17.5 Million
Q1 2021 May 17, 2021	SELL	$23.37 - $31.77 $1.57 Million - $2.14 Million	-67,363 Reduced 4.36%	1,476,479 $36.9 Million
Q4 2020 Feb 16, 2021	BUY	$19.17 - $27.87 $29.6 Million - $43 Million	1,543,842 New	1,543,842 $42.1 Million

Others Institutions Holding TVTX

# of Institutions

239

Shares Held

99.9M

Call Options Held

1.79M

Put Options Held

555K

View Full List

About Travere Therapeutics, Inc.

Ticker TVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,173,600
Market Cap $984M
Description
Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...

More about TVTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account